Status:
COMPLETED
A Pilot Study of the Effect of Personalized Depression Risk Communication
Lead Sponsor:
University of Calgary
Conditions:
Depression
Psychological Distress
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Depression is a highly prevalent and disabling mental health problem. It is associated with significant morbidity and mortality and it has a significant economic impact. Effective and feasible strateg...
Detailed Description
Depression is a highly prevalent and disabling mental health problem. It is associated with significant morbidity and mortality and it has a significant economic impact. Effective and feasible strateg...
Eligibility Criteria
Inclusion
- no MDE at baseline, and full remission for 2 months for those who had a past MDE (see below the question).
- Aged 18+.
- At high risk of MDE based on the algorithms (predicted risk of 6.5%+ for men and 11.2%+ for women).1
- Agreement to be contacted for follow-up assessments, and
- no language barriers to English or French. The status of remission will be assessed by the question: "In the past 2 months or longer, has your mood been much improved or back to normal AND you DIDN'T have the symptoms?"
Exclusion
- NA
Key Trial Info
Start Date :
November 13 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2022
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT04519892
Start Date
November 13 2020
End Date
May 1 2022
Last Update
May 19 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Ottawa Institute of Mental Health Research
Ottawa, Ontario, Canada, K1Z7k4